{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T10:56:25Z","timestamp":1788173785000,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010876","name":"Shanghai University of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["14DZ2271000"],"award-info":[{"award-number":["14DZ2271000"]}],"id":[{"id":"10.13039\/501100010876","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012246","name":"Priority Academic Program Development of Jiangsu Higher Education Institutions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012590","name":"Opening Project of Shanghai Key Laboratory of New Drug Design","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012590","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81573484"],"award-info":[{"award-number":["81573484"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.intimp.2019.106137","type":"journal-article","created":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T23:38:39Z","timestamp":1578613119000},"page":"106137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Demethyleneberberine attenuates concanavalin A-induced autoimmune hepatitis in mice through inhibition of NF-\u03baB and MAPK signaling"],"prefix":"10.1016","volume":"80","author":[{"given":"Miao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingxia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuisong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1 Suppl","key":"10.1016\/j.intimp.2019.106137_b0005","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1016\/j.jhep.2015.03.005","article-title":"Autoimmune hepatitis\u2013Update 2015","volume":"62","author":"Manns","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.intimp.2019.106137_b0010","first-page":"443","article-title":"Amelioration of concanavalin A-induced autoimmune hepatitis by magnesium isoglycyrrhizinate through inhibition of CD4(+)CD25(-)CD69(+) subset proliferation","volume":"10","author":"Yang","year":"2016","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.intimp.2019.106137_b0015","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12916-014-0145-y","article-title":"Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis","volume":"12","author":"Mokdad","year":"2014","journal-title":"BMC Med."},{"issue":"1","key":"10.1016\/j.intimp.2019.106137_b0020","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/liv.13458","article-title":"Autoimmune hepatitis: From current knowledge and clinical practice to future research agenda","volume":"38","author":"Sebode","year":"2018","journal-title":"Liver Int."},{"issue":"1","key":"10.1016\/j.intimp.2019.106137_b0025","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden of liver diseases in the world","volume":"70","author":"Asrani","year":"2019","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.intimp.2019.106137_b0030","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.bbadis.2018.05.017","article-title":"Animal models of autoimmune hepatitis","volume":"1865","author":"Christen","year":"2019","journal-title":"Biochim. Biophys. Acta, Mol. Basis Dis."},{"issue":"12","key":"10.1016\/j.intimp.2019.106137_b0035","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17122007","article-title":"Immunopathogenic mechanisms of autoimmune hepatitis: how much do we know from animal models?","volume":"17","author":"Christen","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.intimp.2019.106137_b0040","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/cmi.2016.3","article-title":"Liver immunology and its role in inflammation and homeostasis","volume":"13","author":"Robinson","year":"2016","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.intimp.2019.106137_b0045","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jaut.2018.10.020","article-title":"Etiopathogenesis of autoimmune hepatitis","volume":"95","author":"Floreani","year":"2018","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.intimp.2019.106137_b0050","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/bs.ircmb.2017.07.007","article-title":"NF-kappaB and the transcriptional control of inflammation","volume":"335","author":"Mitchell","year":"2018","journal-title":"Int. Rev. Cell. Mol. Biol."},{"issue":"2","key":"10.1016\/j.intimp.2019.106137_b0055","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrgastro.2010.213","article-title":"NF-kappaB in the liver\u2013linking injury, fibrosis and hepatocellular carcinoma","volume":"8","author":"Luedde","year":"2011","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.intimp.2019.106137_b0060","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ni0302-221","article-title":"NF-kappaB at the crossroads of life and death","volume":"3","author":"Karin","year":"2002","journal-title":"Nat. Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2019.106137_b0065","doi-asserted-by":"crossref","first-page":"915","DOI":"10.2174\/156800909790192383","article-title":"Gadd45 proteins as critical signal transducers linking NF-kappaB to MAPK cascades","volume":"9","author":"Yang","year":"2009","journal-title":"Curr. Cancer Drug Targets"},{"issue":"3","key":"10.1016\/j.intimp.2019.106137_b0070","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.smim.2014.02.009","article-title":"TNF and MAP kinase signalling pathways","volume":"26","author":"Sabio","year":"2014","journal-title":"Semin. Immunol."},{"issue":"10","key":"10.1016\/j.intimp.2019.106137_b0075","doi-asserted-by":"crossref","first-page":"4759","DOI":"10.4049\/jimmunol.1402954","article-title":"Tissue-specific regulation of p38alpha-mediated inflammation in Con A-induced acute liver damage","volume":"194","author":"Kang","year":"2015","journal-title":"J. Immunol."},{"issue":"31","key":"10.1016\/j.intimp.2019.106137_b0080","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.3748\/wjg.v13.i31.4249","article-title":"Inhibition of p38 mitogen-activated protein kinase attenuates experimental autoimmune hepatitis: involvement of nuclear factor kappa B","volume":"13","author":"Ma","year":"2007","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.intimp.2019.106137_b0085","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1172\/JCI115836","article-title":"A T cell-dependent experimental liver injury in mice inducible by concanavalin A","volume":"90","author":"Tiegs","year":"1992","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.intimp.2019.106137_b0090","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1006\/cyto.2002.1948","article-title":"Cytokine expression in three mouse models of experimental hepatitis","volume":"19","author":"Sass","year":"2002","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.intimp.2019.106137_b0095","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3748\/wjg.v18.i2.119","article-title":"Immune mechanisms of Concanavalin A model of autoimmune hepatitis","volume":"18","author":"Wang","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.intimp.2019.106137_b0100","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.biopha.2018.12.025","article-title":"Glycyrrhizin alleviates Con A-induced hepatitis by differentially regulating the production of IL-17 and IL-25","volume":"110","author":"Zhang","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"1 Suppl","key":"10.1016\/j.intimp.2019.106137_b0105","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/0023677215572841","article-title":"The concanavalin A model of acute hepatitis in mice","volume":"49","author":"Heymann","year":"2015","journal-title":"Lab. Anim."},{"issue":"3","key":"10.1016\/j.intimp.2019.106137_b0110","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1159\/000489074","article-title":"Comparison of concanavalin a-induced murine autoimmune hepatitis models","volume":"46","author":"Ye","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"issue":"7","key":"10.1016\/j.intimp.2019.106137_b0115","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17071036","article-title":"Demethyleneberberine protects against hepatic fibrosis in mice by modulating NF-kappaB signaling","volume":"17","author":"Wang","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.intimp.2019.106137_b0120","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00011-016-1005-3","article-title":"Demethyleneberberine alleviates inflammatory bowel disease in mice through regulating NF-kappaB signaling and T-helper cell homeostasis","volume":"66","author":"Chen","year":"2017","journal-title":"Inflamm. Res."},{"issue":"1","key":"10.1016\/j.intimp.2019.106137_b0125","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1124\/jpet.114.219832","article-title":"Demethyleneberberine, a natural mitochondria-targeted antioxidant, inhibits mitochondrial dysfunction, oxidative stress, and steatosis in alcoholic liver disease mouse model","volume":"352","author":"Zhang","year":"2015","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"4","key":"10.1016\/j.intimp.2019.106137_b0130","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.bbrc.2016.03.019","article-title":"Demethyleneberberine attenuates non-alcoholic fatty liver disease with activation of AMPK and inhibition of oxidative stress","volume":"472","author":"Qiang","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.intimp.2019.106137_b0135","first-page":"182","article-title":"Oxidant stress in type I autoimmune hepatitis: the link between necroinflammation and fibrogenesis?","volume":"1689","author":"Pemberton","year":"2004","journal-title":"BBA"},{"issue":"12","key":"10.1016\/j.intimp.2019.106137_b0140","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1007\/s10620-014-3267-3","article-title":"Low serum vitamin D levels are associated with severe histological features and poor response to therapy in patients with autoimmune hepatitis","volume":"59","author":"Efe","year":"2014","journal-title":"Dig. Dis. Sci."},{"issue":"12","key":"10.1016\/j.intimp.2019.106137_b0145","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1124\/dmd.106.011361","article-title":"Pharmacokinetics of berberine and its main metabolites in conventional and pseudo germ-free rats determined by liquid chromatography\/ion trap mass spectrometry","volume":"34","author":"Zuo","year":"2006","journal-title":"Drug Metab. Dispos."},{"issue":"1","key":"10.1016\/j.intimp.2019.106137_b0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mcna.2013.09.005","article-title":"Evaluation of abnormal liver tests","volume":"98","author":"Woreta","year":"2014","journal-title":"Med. Clin. North Am."},{"issue":"5","key":"10.1016\/j.intimp.2019.106137_b0155","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.jhep.2013.06.013","article-title":"Oxidative albumin damage in chronic liver failure: relation to albumin binding capacity, liver dysfunction and survival","volume":"59","author":"Oettl","year":"2013","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.intimp.2019.106137_b0160","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/hep.21498","article-title":"IL-10, regulatory T cells, and Kupffer cells mediate tolerance in concanavalin A-induced liver injury in mice","volume":"45","author":"Erhardt","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2019.106137_b0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cytogfr.2016.05.001","article-title":"STAT3 signaling in immunity","volume":"31","author":"Hillmer","year":"2016","journal-title":"Cytokine Growth Factor Rev."},{"issue":"2","key":"10.1016\/j.intimp.2019.106137_b0170","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/03602532.2017.1306544","article-title":"The metabolism of berberine and its contribution to the pharmacological effects","volume":"49","author":"Wang","year":"2017","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.intimp.2019.106137_b0175","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3389\/fphar.2018.00557","article-title":"Berberine: botanical occurrence, traditional uses, extraction methods, and relevance in cardiovascular, metabolic, hepatic, and renal disorders","volume":"9","author":"Neag","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2019.106137_b0180","doi-asserted-by":"crossref","first-page":"6150","DOI":"10.12659\/MSM.907377","article-title":"The Effects of berberine on Concanavalin A-induced autoimmune hepatitis (AIH) in mice and the adenosine 5'-monophosphate (AMP)-activated protein kinase (AMPK) pathway","volume":"23","author":"Wang","year":"2017","journal-title":"Med. Sci. Monit."},{"issue":"10","key":"10.1016\/j.intimp.2019.106137_b0185","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1007\/s10620-016-4247-6","article-title":"Nature and implications of oxidative and nitrosative stresses in autoimmune hepatitis","volume":"61","author":"Czaja","year":"2016","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.intimp.2019.106137_b0190","doi-asserted-by":"crossref","first-page":"7891574","DOI":"10.1155\/2016\/7891574","article-title":"Oxidative stress and liver cancer: etiology and therapeutic targets","volume":"2016","author":"Wang","year":"2016","journal-title":"Oxid. Med. Cell Longev."},{"issue":"1","key":"10.1016\/j.intimp.2019.106137_b0195","first-page":"190","article-title":"Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor","volume":"21","author":"Gantner","year":"1995","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.intimp.2019.106137_b0200","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1136\/gut.2008.165647","article-title":"A novel technique for selective NF-kappaB inhibition in Kupffer cells: contrary effects in fulminant hepatitis and ischaemia-reperfusion","volume":"58","author":"Hoffmann","year":"2009","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.intimp.2019.106137_b0205","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/jat.1393","article-title":"NF-kappaB in liver diseases: a target for drug therapy","volume":"29","author":"Muriel","year":"2009","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.intimp.2019.106137_b0210","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.intimp.2017.09.022","article-title":"Hepatoprotective effect of quercetin against LPS\/d-GalN induced acute liver injury in mice by inhibiting the IKK\/NF-kappaB and MAPK signal pathways","volume":"52","author":"Peng","year":"2017","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2019.106137_b0215","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.cbi.2017.07.012","article-title":"Antimalarial agent artesunate protects Concanavalin A-induced autoimmune hepatitis in mice by inhibiting inflammatory responses","volume":"274","author":"Zhao","year":"2017","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.intimp.2019.106137_b0220","doi-asserted-by":"crossref","first-page":"2748367","DOI":"10.1155\/2016\/2748367","article-title":"Shikonin attenuates Concanavalin A-induced acute liver injury in mice via inhibition of the JNK pathway","volume":"2016","author":"Liu","year":"2016","journal-title":"Med. Inflamm."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576919315413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576919315413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T21:41:51Z","timestamp":1762551711000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576919315413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":44,"alternative-id":["S1567576919315413"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2019.106137","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Demethyleneberberine attenuates concanavalin A-induced autoimmune hepatitis in mice through inhibition of NF-\u03baB and MAPK signaling","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2019.106137","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106137"}}